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Despite 53 million saved lives in the last 20 years, tubercu-
losis (TB) remains one of the top ten leading causes of
death in the world. TB incidence in Latvia is one of the
highest among Baltic and Eastern European countries
(Anonymous, 2017). According to statistical data, 24.8 new
cases per 100 000 people were registered in Latvia in 2017.
This is the lowest indicator since 1991. However, the mor-
tality of TB has remained significant. One of the regions
with the highest TB incidence is Latgale with 31.1 cases per
100 000 people (Anonymous, 2018).
The region of Latgale is located in the southeast part of Lat-
via. It borders the Russian Federation, Republic of Belarus,
and Lithuania. Spanning a few centuries, many different
ethnicities have lived in this region — Latvians, Russians,
Belarusians, Poles, and other ethnic groups (Anonymous,
2002). The aim of this pilot study was to explore markers of
genetic predisposition to TB in the region of Latgale.
Human Leucocyte Antigens (HLA) of the Major Histocom-
patibility Complex are among factors affecting susceptibil-
ity for TB. Findings have demonstrated that the HLA Class
II region contributes to the genetic risk of TB, possibly
through the reduced presentation of protective Mycobacte-
rium tuberculosis antigens to T helper cells (Sveinbjornsson
et al., 2016).
In Central Asia, HLA-DRB1*08:01, HLA-DRB1*08:03,
HLA-DQA1*03:02, HLA-DQA1*03:03 , and HLA-
DQB1*06:01 alleles were discovered to be TB risk alleles
(Kuranov et al., 2014). Among Korean TB patients, HLA-
DRB1*08 and HLA-DQB1*06 alleles demonstrated also in-
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Tuberculosis (TB) is still one of the top ten leading causes of death in the world. Compared to
other Baltic and Eastern European countries, TB incidence (24.8 new cases per 100 000 people
in 2017) in Latvia is relatively high. One of the regions with the highest TB incidence is Latgale
(31.1 cases per 100 000 people). The aim of this pilot study was to identify markers of genetic
predisposition to TB in Latgale. The study included 26 patients (16 males and 10 females) aged
between 18 and 85 with bilateral TB pneumonia and without HIV infection. HLA typing was per-
formed in HLA-DRB1, -DQA1, and -DQB1 loci by a polymerase chain reaction with low resolution
sequence-specific primers. HLA-DRB1*07 and HLA-DRB1*11 alleles were identified as risk al-
leles for TB. HLA-DRB1*15 allele was a protective allele. Due to the limitations of this exploratory
study, a broader study needs to be conducted to revealing specific risk and protective HLA Class
II alleles for TB in the subpopulation of Latgale.
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creased risk of TB (Kim et al., 2005). In the Northwest re-
gion of Russia, the HLA-DRB1*04 allele was identified as a
risk allele of TB (Starshinova et al., 2015). In Iran, TB is
associated with HLA-DB1*07 and HLA-DQA1*01:01
(Amirzargar et al., 2004). In Europe, TB is associated with
the presence of different alleles in the genotype. In Poland,
TB developed most often in people with HLA-DRB1*16:01
and HLA-DQB1*05:02 alleles (Dubaniewicz et al., 2005);
in Italy with HLA-DRB1*04 (Ruggiero et al., 2004), and in
Portugal, risk was increased with presence of the HLA-
DRB1*14 allele (Duarte et al., 2011). Therefore, different
alleles are associated with TB in different populations. It
should be noted that there is no available data regarding TB
patients HLA Class II gene profile in Latvia and its regions.
This study started in October of 2017. Permissions of the
Ethics Committee of Rîga East Clinical University Hospital
and the Central Medical Ethics Committee, Rîga, Latvia,
were obtained for the genetic analysis. Patients of the Lung
Disease and Tuberculosis Ward of Daugavpils Regional
Hospital participated in the study after signing an agree-
ment. These patients formed the target sample of TB pa-
tients in the period between October 2017 and September
2018. Inclusion criteria were: 18 years of age or older, not
pregnant, not incarcerated, confirmed pulmonary TB, and
negative HIV1/2 test result.
The pilot study group was composed of 26 patients (16
males and 10 females) aged between 18 and 85 (mean age
was 50). In all patients, bilateral TB pneumonia was con-
firmed. At the time of the study, 25 patients were undergo-
ing first-line anti-TB therapy and one patient was undergo-
ing second-line anti-TB therapy because of primary
resistance of Mycobacterium tuberculosis. Among the pa-
tients, three afflicted relatives (two siblings and their parent)
were detected. This factor was controlled at the step of the
data analysis.
HLA typing was performed in HLA-DRB1, -DQA1, and
-DQB1 loci by a polymerase chain reaction with low resolu-
tion sequence-specific primers (DNA-Technology, Russia)
according to the manufacturer instruction. DNA extraction
was performed by using the QIAamp® DNA Blood Kit
(QIAGEN, Germany) according to the manufacturer in-
struction. Amplification was performed using a thermocy-
cler “DT-Lite” (DNA-Technology, Russia). For genetic
analysis, 5 ml of blood with EDTA was used and stored at
–20 °C. To determine risk and protective alleles of the HLA
Class II gene, HLA-profiles of 100 people (without active
TB) were used. This control group included blood donors
without HIV infection, viral hepatitis C and cytomegalo-
virus infection aged from 18 to 65 years. No relatives were
involved in this group. In both subsamples — clinical and
control — the same protocol for DNA isolation and HLA
typing was applied. The analysis was conducted in the Joint
Laboratory of Clinical Immunology and Immunogenetics of
Rîga Stradiòð University.
IBM SPSS 22.0 was used for the statistical analysis. Fre-
quencies of alleles were compared using the Pearson’s chi-
square test. The Odds ratio (OR) was calculated with the
Cochrane-Mantel-Haenszel test.
The research results are presented in Table 1. The results
showed that HLA-DRB1*07 (OR = 7.20) and HLA-
DRB1*11 (OR = 8.56) were presented more frequently in
patients with TB than in the control group, while HLA-
DRB1*15 was presented less frequently in patients with TB
than in the control group (OR = 0.20). HLA-DRB1*07 and
HLA-DRB1*11 alleles were identified as risk alleles for TB.
In contrast, the HLA-DRB1*15 was protective allele. It
should be noted that excluding the siblings from the analy-
sis did not change the revealed effects of the alleles.
Two alleles concurred with the results of other studies.
HLA-DRB1*15 was a protective allele for the development
of pulmonary TB among children in Northwest Russia
(Starshinova et al., 2015). HLA-DRB1*07 was identified as
a risk allele in a study on Iranian TB patients (Amirzargar et
al., 2004). The HLA-DRB1*07 allele was also among the
risk alleles for Latvian Lyme disease patients and was
strongly associated with the development of severe forms of
neuroborreliosis (Kovalchuka et al., 2016). Therefore, this
allele is not specific for TB.
We did not find a negative effect of other alleles (HLA-
DRB1*08, *14, *16, HLA-DQA1*03, HLA-DQB1*05, and
*06), which were described in other populations
(Dubaniewicz et al., 2005; Kim et al., 2005; Duarte et al.,
2011; Kuranov et al., 2014).
The effects of the alleles cannot be generalised to any popu-
lation. In contrast to our study, HLA-DRB1*07:01 was asso-
ciated with a reduced incidence of pulmonary TB in Asian
populations (Li et al., 2015), and HLA-DRB1*15 was an al-
lele responsible for susceptibility to TB in China (Wang et
al., 2005), and in Central India (Mishra et al., 2014).
T a b l e 1






2 p OR OR 95% CI p
HLA-DRB1*07 0.23 0.04 10.28 0.001 7.20 (1.86; 27.88) 0.004
HLA-DRB1*11 0.56 0.12 22.08 0.000 8.56 (3.21; 22.77) 0.000
HLA-DRB1*15 0.12 0.39 7.00 0.008 0.20 (0.06; 0.73) 0.014
TB, tuberculosis; frel, relative frequency; OR, odds ratio; CI, confidence interval.
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Despite a relatively high statistical significance, the ex-
ploratory study had an important limitation associated with
the size of the clinical sample. Therefore, the results show
only possible risk or protective alleles. Further study is
needed for more precise assessment of the role of alleles,
associated odds ratio, and confidence intervals. A region-
specific control group should be included in the study as-
sessing region-specific risk or protective alleles.
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ÌENÇTISKÂS PREDISPOZÎCIJAS MARÍIERU PILOTPÇTÎJUMS PACIENTIEM AR TUBERKULOZES PNEIMONIJU LATGALÇ
Tuberkuloze (TB) joprojâm ir viens no desmit galvenajiem nâves cçloòiem pasaulç. Salîdzinot ar citâm Baltijas un Austrumeiropas valstîm,
TB incidence Latvijâ ir samçra augsta (24,8 jauni gadîjumi uz 100 000 iedzîvotâjiem 2017. gadâ). Savukârt, Latvijas reìions ar augstâku
TB incidenci ir Latgale (31,1 jauni gadîjumi uz 100 000 iedzîvotâjiem). Pilotpçtîjuma mçríis bija izpçtî TB ìençtiskâs predispozîcijas
maríierus Latgalç. Pçtîjuma izlasi veidoja 26 pacienti (16 vîrieði un 10 sievietes) vecumâ no 18 lîdz 85 gadiem ar abpusçju tuberkulozes
pneimoniju un bez HIV infekcijas. HLA tipçðana HLA-DRB1, -DQA1 un -DQB lokusos bija veikta ar polimerâzes íçdes reakciju ar zemas
rezolûcijas sekvences specifiskajiem praimeriem. Alçles HLA-DRB1*07 un HLA-DRB1*11 bija identificçtas kâ TB riska alçles,
HLA-DRB1*15 bija protektîva alçle. Pçtîjuma ierobeþojumi râda, ka ir jâveic plaðâks pçtîjums, lai atklâtu specifiskâs TB riska un
protektîvâs HLA II klases alçles Latgales reìionâ.
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